#Germany #Berlin #Women's Health #MENO! App #Sidekick Health

Sidekick Health Launches MENO! App

Sidekick Health, a prominent digital health company, has announced an exciting step forward in women's healthcare with the launch of a new clinical study focused on their latest digital therapeutic product, the MENO! App. This app is specifically intended to meet the needs of women undergoing menopause, a phase often marked by a variety of challenging symptoms.

Addressing Women's Health Gaps

For years, women's health has faced systemic neglect within the medical field. Despite representing half of the global population, women frequently encounter a lack of tailored medical research and healthcare services. Menopause is a prime example—many women experience severe symptoms, including hot flashes, sleep disturbances, and mood swings, all of which can significantly disrupt their daily lives and careers. Unfortunately, existing treatment options are frequently limited and not widely accessible.

Prof. Dr. Pia Wülfing, Chief Clinical Officer at Sidekick Health and a practicing OB/GYN, emphasized the company's mission: "We invest in innovative digital health solutions that address the individual needs of women at various stages of life. Our focus lies in combining technology with medical expertise to improve healthcare outcomes."

A New Era of Menopause Management

The MENO! App breaks new ground as a CE-marked digital therapeutic specifically designed to alleviate symptoms associated with menopause. This innovative app offers an alternative to traditional menopause treatments that often rely heavily on Menopause Hormone Therapy (MHT). Instead, the MENO! App provides users with evidence-based cognitive behavioral therapy (CBT), focusing on non-hormonal methods to support women in managing their symptoms holistically.

Notably, the app integrates behavioral interventions with lifestyle support, equipping users with personalized tools catered to their health requirements. With this approach, the MENO! App empowers women to take charge of their health during menopause and beyond.

Pioneering Research in Women's Health

In an effort to underpin the effectiveness of the MENO! App, Sidekick is initiating a decentralized, randomized-controlled clinical study in Germany. This study marks a significant milestone in women's health technology, particularly as Sidekick Health Group currently holds two prescription digital therapeutics (PDTs) within Germany's DiGA formulary—PINK! Coach and zanadio.

The upcoming study will enroll women aged 40-65 who are experiencing troubling menopausal symptoms, dividing participants into two groups: one that utilizes the MENO! App and another that receives standard care. Upon completion, the control group will also gain access to the app, ensuring equitable benefits for all involved.

Sidekick Health has already issued over 100,000 prescriptions and supports 16,000 healthcare providers in Germany, solidifying its role as a leader in the realm of prescription digital therapeutics. The launch of the MENO! App adds a crucial component to its offerings, championing the cause of comprehensive, science-driven solutions for women's health.

Commitment to Comprehensive Women's Care

Having demonstrated success with digital health solutions in maternal care, Sidekick Health is now extending its reach into menopause management, thus reaffirming its commitment to women's health at every stage of life. Prior programs have been instrumental in enhancing pregnancy outcomes, decreasing neonatal intensive care unit (NICU) admissions, and helping stabilize maternal blood glucose and blood pressure.

The introduction of the MENO! App symbolizes a proactive stride towards bridging existing gaps in women's healthcare. In creating accessible digital therapeutics, Sidekick Health is transforming the landscape of treatment by ensuring that women's health receives the attention and innovation it deserves.

The Future of Women's Health

As digital therapeutics continue to evolve, Sidekick Health advocates for solutions that go beyond mere engagement; they must provide tangible results and improvements in health outcomes. The MENO! App exemplifies this vision, establishing a new benchmark in menopause care, demonstrating that innovation in women's health is both essential and overdue.

For further information regarding the MENO! App and the ongoing clinical study, interested individuals can visit MENO! App Website.